Quick summary of cryo-EM

Cryo-EM evolved from electron microscopy (EM) developed in the 1930s, with a pivotal breakthrough in the 1980s when Jacques Dubochet introduced vitrification, enabling high-resolution imaging of hydrated biological specimens. Subsequent contributions by Joachim Frank (computational algorithms for single-particle analysis) and Richard Henderson (determination of bacteriorhodopsin’s atomic structure by EM) established cryo-EM as a transformative structural biology tool. The 2012 "resolution revolution," driven by direct electron detectors (DEDs), culminated in the trio’s 2017 Nobel Prize in Chemistry. 

The cryo-EM workflow begins with rapid vitrification of purified biomolecules in liquid ethane, immobilizing them in near-native states. These samples are imaged under high-powered transmission electron microscopes (TEMs), generating thousands of low-dose micrographs. Computational processing—including particle picking, 2D classification, ab initio reconstruction, and iterative 3D refinement—yields atomic-resolution density maps, enabling model building of macromolecular structures.  

Unlike X-ray crystallography, cryo-EM circumvents crystallization requirements, excelling in structural determination of membrane proteins, large complexes, and flexible assemblies. A key advantage is its capacity to resolve multiple conformational states, providing mechanistic insights into dynamic biological processes. In drug discovery, cryo-EM elucidates ligand-target interactions at near-atomic resolution, facilitating structure-based drug design (SBDD). Notably, during the COVID-19 pandemic, cryo-EM enabled rapid determination of the SARS-CoV-2 spike protein structure, expediting therapeutic and vaccine development.  

Future advancements include automated sample preparation, AI-enhanced image processing, and time-resolved cryo-EM for capturing transient intermediates. Cryo-electron tomography (cryo-ET) further extends applicability by visualizing macromolecules within cellular contexts. Despite challenges—such as high equipment costs and specialized expertise—cryo-EM is increasingly indispensable in biomedical research. Its ability to solve previously intractable structures accelerates therapeutic development, particularly for personalized medicine. Integration with complementary techniques (e.g., mass spectrometry, XFEL) promises enhanced structural and functional insights. As methodological innovations continue, cryo-EM is poised to address fundamental biological questions and streamline global drug discovery pipelines.  

Study material for Cryo-EM basics

 Tutorial Playlists 

 Online resources 

 Data processing software we use